6 hours Ago
Enanta Pharma ( NASDAQ: ENTA ) is scheduled to announce Q4 earnings results on Monday, November 25th, after market close. The consensus EPS Estimate is -$0.92 (+30.
8% Y/Y) and the consensus Revenue Estimate is $17.83M (-5.8% Y/Y).
Over the last 2 years, ENTA has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time. More on Enanta Pharma Seeking Alpha’s Quant Rating on Enanta Pharma Historical earnings data for Enanta Pharma Financial information for Enanta Pharma.
